Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA minor update shows Revision: v3.3.2 in the page footer, replacing Revision: v3.2.0; there are no changes to core study content such as eligibility criteria or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved the government funding/operating status notice from the study page; the core trial details remain unchanged.SummaryDifference0.4%

- Check40 days agoChange DetectedThe new screenshot shows the same study record with only minor UI/layout changes and updated dates; there are no changes to study results, eligibility criteria, enrollment numbers, or key study details.SummaryDifference0.5%

- Check61 days agoChange Detected- Added a government funding notice and operating status information, and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check69 days agoChange DetectedCore content related to Sickle cell anemia was removed; a new version tag v3.1.0 was added to the page while the previous version tag v3.0.2 was removed.SummaryDifference0.7%

- Check83 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.3%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.